Immobilization of Plasminogen Activator, Urokinase, on Nylon

Summary

Urokinase (UK), a fibrinolytic enzyme activator purified from human material was immobilized on nylon using different procedures. One was a modified method of immobilization of antigen or antibody initially carried out by Edelman and others in 1971 (Procedure I). The other was our newly devised method (Procedure II) (Sugitachi et al. 1976).

Major specificities of the immobilized UK are as follows:

1. The UK revealed properties of a plasminogen activator and the optimum pH of the immobilized UK was between 7.2 and 7.4, these values being in good parallel with that of soluble UK. The immobilized UK maintained a stable fibrinolytic activity after long-term preservation and heat-treatment.

2. As the fibrinolytic activity of immobilized UK was found to be inhibited by the antiplasmin in human plasma, an antiplasmin inhibitor was immobilized on the nylon together with the UK.

The antiplasmin activity was to some extent prevented using this procedure.

3. Nylon tubes immobilized with UK and antiplasmin inhibitor were used for thrombotic coagulation studies carried out according to the method of Chandler. Thrombus formation time (TFT) of UK-immobilized tubes was 30 min, while that of the non-treated tubes was no longer than 10 min.

• References

• 1 Aoki N, Matsuda M, Morii M, Yoshida N. 1975; Acceleration of urokinase-induced clot lysis in vitro by synthetic compound. The Journal of Medical Enzymology 1: 471 (in Japanese)
• 2 Asada T, Igarashi Y. 1974; Laboratory examinations on fibrinolysis employing lysine agarose. THE Journal of Medical Enzymology 1: 14 (in Japanese)
• 3 Astrup T, Müllertz S. 1952; The Fibrin Plate Method for Estimating Fibrinolytic Activity. Archives of Biochemistry and Biophysics 40: 346
• 4 Back N, Ambrus JL, Mink IB. 1961; Distribution and Fate of I¹³¹-Labeled Components of the Fibrinolysin System. Circulation Research IX: 1208
• 5 Chandler AB. 1958; In Vitro Thrombotic Coagulation of the Blood. Laboratory Investigation 7: 110
• 6 Edelman GM, Rutishauser U, Millette CF. 1971; Cell Fractionation and Arrangement on Fibers, Beads, and Surfaces. Proceedings of the National Academy of Sciences 68 9 2153
• 7 Hishimoto T, Idei K. 1971; Estimation of Fibrinogen Level in the Human Plasma by Turbidimetric Method. The Japanese Journal of Clinical Pathology 19: 253 (in Japanese)
• 8 Moroz LA, Gilmore NJ. 1975; A Rapid and Sensitive ¹²⁵I-Fibrinogen Solid-Phase Fibrinolytic Assay for Plasmin. Blood 46: 543
• 9 Nanninga L, Guest M. 1974; Blocking of the Fibrinolytic Antiactivator by Substituted Benzoates. Life Sciences 14: 2507
• 10 Ohta E, Miura Y, Tozawa Y. 1972; Fibrin-Agar Plate Method, a new method for estimation of fibrinolytic activity. The Japanese Journal of Clinical Hematology 13 (5) 793 (in Japanese)
• 11 Rickli EE. 1975; The Activation Mechanism of Human Plasminogen. Thrombosis et Diathesis Haemorrhagica 34: 386
• 12 Sugitachi A, Hong SD, Ohshiro T, Kosaki G. 1976 Immobilization of Fibrinolytic Enzyme, Urokinase. X International Congress of Angiology Proceedings. (Tokyo, Japan) 213
• 13 Tajima H, Ishiguro J, Nonaka R, Kurita M, Tanaka S, Ogawa N. 1974; Metabolic Fate of Urokinase. Chemical and Pharmaceutical Bulletin 22: 111
• 14 Ueno T, Takeuchi T, Takahashi M, Arai H, Kobayashi N, Maekawa T, Tsukada H. 1975; Studies on Metabolism of ¹²⁵I-Urokinase (III). The Journal of Medical Enzymology 1: 703 (in Japanese)
• 15 Von Kaulla KN, Davidson JF. 1974. Synthetic Fibrinolytic Thrombolytic Agents. Charles C. Thomas Publisher; U.S.A:
• 16 Wakayama Y, Satake K, Tsunematsu T, Fukase M. 1974; Studies on Urokinase (UK) Therapy of Thrombotic Diseases. The Journal of Japanese College of Angiology 14 7 581
• 17 Woodard WT, Day ED, Silver D. 1970; The fate of infused urokinase. Surgery 68 4 692